Watch Videos Online

Mylan CEO on FDA-approved biosimilar, Trumps drug price plan

CBS This Morning News-Politics 2018-06-12 - 13:13:04

"Nearly two years after taking tremendous heat for the rising cost of EpiPens, pharmaceutical giant Mylan is making strides in the fast-growing biosimilar market. Biosimilars are drugs and devices made to be similar to already-approved products, potentially lowering the cost of treatment. Mylan won FDA approval last week for a biosimilar drug designed to help some cancer patients reduce infection risk during chemotherapy. Mylan CEO Heather Bresch joins CBS This Morning to explain how biosimilars could translate to patient savings, what the company learned from the EpiPen debacle, and why she applauds President Trumps plan to reduce drug costs. Subscribe to the CBS This Morning Channel HERE: Watch CBS This Morning HERE: Watch the latest installment of Note to Self, only on CBS This Morning, HERE: Follow CBS This Morning on Instagram HERE: Like CBS This Morning on Facebook HERE: Follow CBS This Morning on Twitter HERE: Follow CBS This Morning on Google+ HERE: Get the latest news and best in original reporting from CBS News delivered to your inbox. Subscribe to newsletters HERE: Get your news on the go! Download CBS News mobile apps HERE: Get new episodes of shows you love across devices the next day, stream local news live, and watch full seasons of CBS fan favorites anytime, anywhere with CBS All Access. Try it free! Delivered by Norah O’Donnell and Gayle King, CBS This Morning offers a thoughtful, substantive and insightful source of news and information to a daily audience of 3 million viewers. The Emmy Award-winning broadcast presents a mix of daily news, coverage of developing stories of national and global significance, and interviews with leading figures in politics, business and entertainment. Check local listings for CBS This Morning broadcast times."

Sign up to our newsletter

Don't miss any trending posts!